Biotechnology Reagents Market Report 2026

The biotechnology reagents market size has grown strongly in recent years. It will grow from $92.14 billion in 2025 to $101.21 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to expansion of biotechnology research activities, growth in pharmaceutical R&D spending, increasing adoption of molecular diagnostics, rising academic research funding, availability of advanced laboratory infrastructure.

The biotechnology reagents market size is expected to see rapid growth in the next few years. It will grow to $148.21 billion in 2030 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, expansion of genomics and proteomics research, rising investments in personalized medicine, growing adoption of automated lab systems, increasing focus on reproducibility in research. Major trends in the forecast period include increasing demand for high-purity molecular biology reagents, rising adoption of advanced analytical reagents, growing use of pcr and gene expression kits, expansion of automated laboratory workflows, enhanced focus on reagent consistency and accuracy.

The increasing demand for polymerase chain reaction (PCR) is anticipated to drive the growth of the biotechnology reagents market in the coming years. Polymerase chain reaction (PCR) is a molecular technique used to amplify small segments of DNA into larger segments, which are utilized to diagnose specific infectious diseases and study genetic variations. In polymerase chain reaction (PCR), biotechnology reagents are employed to maintain a stable pH during the PCR process, ensuring proper DNA synthesis, which can subsequently be used for various genomic studies and diagnostic purposes. For example, in March 2025, the World Health Organization, a Switzerland-based United Nations specialized agency responsible for international public health, reported that during the four-week period from 6 January to 2 February 2025, weekly SARS-CoV-2 PCR positivity monitored through systematic virological surveillance decreased from 7.3% in the first week to 5% in the last week, with a weekly average of over 69,900 specimens tested across 103 countries. Consequently, the growing demand for polymerase chain reaction (PCR) is contributing to the expansion of the biotechnology reagents market.

Major companies in the biotechnology reagent market are concentrating on product innovation to enhance their standing in the industry. Product innovation entails creating new or improved biotechnology reagents that improve research capabilities, diagnostic precision, or analytical performance. For example, in May 2023, Bio-Techne, a global life sciences company involved in the development, manufacturing, and sale of life science reagents, announced the launch of two new RNAscope in situ Hybridization Probes, Kappa and Lambda, as analyte-specific reagents (ASRs). These probes are biotechnology reagents intended for detecting immunoglobulin kappa and lambda light chain mRNA in B-cells, representing a notable advancement for both research and clinical diagnostic purposes. This development facilitates enhanced molecular detection and broadens the capabilities available to the research and clinical diagnostic communities.

In December 2023, Danaher Corporation, a US-based supplier of life sciences instruments, reagents, and consumables for biotechnology and diagnostics applications, acquired Abcam plc for an undisclosed amount. Through this acquisition, Danaher intends to expand its biotechnology reagents portfolio, increase its global presence in life-science research and diagnostics, and accelerate innovation in reagent development for biopharmaceutical and academic markets. Abcam plc is a UK-based supplier of research antibodies, proteins, and reagent kits utilized in biotechnology, molecular biology, and diagnostic applications.

Major companies operating in the biotechnology reagents market are Life Technologies Corporation, Abbott Laboratories, Abcam PLC, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, BioLegend Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology, Danaher Corp., General Electric incorporated, Hoefer Inc., Illumina Inc., Lonza Group Ltd., Merck KGaA Group, Meridian Bioscience Inc., Millipore Corporation, New England Biolabs Inc., Novus Biologicals LLC, PerkinElmer Inc., Promega Corporation, Quality Biological Inc., Roche Holding AG, Siemens Healthineers AG, Sigma-Aldrich Corp., Sysmex Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Tosoh Corporation.

North America was the largest region in the biotechnology reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biotechnology reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biotechnology reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the biotechnology reagents market by increasing costs of imported chemicals, enzymes, antibodies, laboratory consumables, and analytical instruments used in research and diagnostics. Research institutes and pharmaceutical companies in North America and Europe are most affected due to reliance on imported reagents, while Asia-Pacific faces cost pressures on reagent exports. These tariffs are increasing research costs and procurement timelines. At the same time, they are encouraging domestic reagent manufacturing, regional supply chain development, and localized production of critical biotech inputs.

The biotechnology reagents market research report is one of a series of new reports that provides biotechnology reagents market statistics, including biotechnology reagents industry global market size, regional shares, competitors with a biotechnology reagents market share, detailed biotechnology reagents market segments, market trends and opportunities, and any further data you may need to thrive in the biotechnology reagents industry. This biotechnology reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biotechnology reagents are chemical compounds utilized in detecting, measuring, and preparing products, among other functions, by facilitating chemical processes. They are employed in the quantification and detection of target substances, as the interaction of reagents with these substances or related compounds initiates specific reactions.

The primary categories of biotechnology reagents include life science reagents, analytical reagents, and other reagents. Life science reagents are substances used in chemical reactions to observe data changes and analyze them to identify the cause of a disease. They find applications in areas such as protein synthesis and purification, gene expression, DNA and RNA analysis, and drug testing. The end-users of these reagents include biotech companies, research institutes, pharmaceutical firms, diagnostic centers, academic institutions, and other organizations.

The biotechnology reagents market includes revenues earned by entities by chromatography, in-vitro diagnostics, polymerase chain reaction and cell culture technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.